menu
    • menu

    Company profile for C-Path

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently ...
    Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    C-PathUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1840 E River Rd, Suite 100 Tucson, AZ 85718
    Telephone
    Telephone
    +1 5205473440
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://c-path.org/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/the-critical-path-institute
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cpathinstitute?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    C-Path's Disease Modeling Coalition Initiate Global Pediatric IBD
    C-Path's Disease Modeling Coalition Initiate Global Pediatric IBD

    16 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/c-paths-disease-modeling-coalition-begins-global-pediatric-ibd-work-from-european-hub-302585865.html

    PR NEWSWIRE
    16 Oct 2025
    Share Share
    C-Path Paper Urges Regulatory Impact From Consortium Work
    C-Path Paper Urges Regulatory Impact From Consortium Work

    16 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/c-paths-new-paper-in-nature-reviews-drug-discovery-highlights-how-to-maximize-the-regulatory-impact-of-consortium-based-projects-302482766.html

    PR NEWSWIRE
    16 Jun 2025
    Share Share
    C-Path And CENTOGENE MOU To Enhance Collaboration In Lysosomal Disease Research
    C-Path And CENTOGENE MOU To Enhance Collaboration In Lysosomal Disease Research

    20 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/20/2901655/0/en/C-Path-and-CENTOGENE-MOU-to-Enhance-Collaboration-in-Lysosomal-Disease-Research-and-Drug-Development.html

    GLOBENEWSWIRE
    20 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search